Article
Global cellular proteo-lipidomic profiling of diverse lysosomal storage disease mutants using nMOST.
Science advances - 24 Jan 2025
Kraus Felix, He Yuchen, Swarup Sharan, Overmyer Katherine A, Jiang Yizhi, Brenner Johann, Capitanio Cristina, Bieber Anna, Jen Annie, Nightingale Nicole M, Anderson Benton J, Lee Chan, Paulo Joao A, Smith Ian R, Plitzko Jürgen M, Gygi Steven P, Schulman Brenda A, Wilfling Florian, Coon Joshua J, Harper J Wade
Abstract excerpt
Lysosomal storage diseases (LSDs) comprise ~50 monogenic disorders marked by the buildup of cellular material in lysosomes, yet systematic global molecular phenotyping of proteins and lipids is lacking. We present a nanoflow-based multiomic single-shot technology (nMOST) workflow that quantifies HeLa cell proteomes and lipidomes from over two dozen LSD mutants. Global cross-correlation analysis between lipids and...
Read the complete abstract on PubMedTopics
- Humans
- Lysosomal Storage Diseases
- HeLa Cells
- Mutation
- Lysosomes
